Viewing Study NCT01022918


Ignite Creation Date: 2025-12-25 @ 4:49 AM
Ignite Modification Date: 2025-12-26 @ 3:51 AM
Study NCT ID: NCT01022918
Status: COMPLETED
Last Update Posted: 2012-09-25
First Post: 2009-11-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Evaluation of the Irinotecan/Bevacizumab Association for Naive Unresectable Glioblastoma
Sponsor: Centre Georges Francois Leclerc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module